Furthermore, we noticed higher expression of immune checkpoints on CD8+ T‐cells (Figure 2J–L), which inspired us to investigate the potential alteration of PD‐L1 expression on HCC cells as well. The gene discussed is CD8A; the disease is hepatocellular carcinoma.